Pharming

www.pharming.com

PO Box 451
Leiden
2300 AL Leiden
Netherlands

+31 71 5247 400

Activities

Research & Development | Cardiovascular | Pharmaceutical

Related Companies

Related Content

Therapeutic: leniolisib for APDS
Therapeutic: leniolisib for APDS
Pharming enrols first patient in Ruconest COVID-19 study
Pharming enrols first patient in Ruconest COVID-19 study
Pharming to build downstream processing facility in Oss
Pharming to build downstream processing facility in Oss
FDA approves new facility for Pharming Group biologic production
FDA approves new facility for Pharming Group biologic production
European Commission amends Marketing Authorisation for RUCONEST to include self-administration
European Commission amends Marketing Authorisation for RUCONEST to include self-administration
Pharming announces completion of financing for RUCONEST North American Rights Acquisition
Pharming announces completion of financing for RUCONEST North American Rights Acquisition
Perry Calias joins Pharming as Chief Scientific Officer
Perry Calias joins Pharming as Chief Scientific Officer
Pharming agrees collaboration with Shanghai Institute of Pharmaceutical Industry (SIPI)
Pharming agrees collaboration with Shanghai Institute of Pharmaceutical Industry (SIPI)
Pharming announces restructuring plan
Pharming announces restructuring plan
Renova Life to supply founder transgenic rabbits to Pharming
Renova Life to supply founder transgenic rabbits to Pharming
Approved nces find their niche
Approved nces find their niche
EC grants marketing authorisation to Ruconest
EC grants marketing authorisation to Ruconest
Pharming signs manufacturing deal with Sanofi Chimie
Pharming signs manufacturing deal with Sanofi Chimie
Pharming to divest DNage subsidiary
Pharming to divest DNage subsidiary